A state-by-state guide for cardiologists seeking the most rewarding places to build their careers, blending compensation, lifestyle, and growth potential.
In a meta-analysis of 4566 patients with COVID-19, researchers found no statistically significant increase in cardiac adverse events associated with remdesivir treatment and concluded that the drug does not raise heart-related safety concerns.
Researchers used blood proteins to estimate the biological age of 11 organs in over 44,000 people, revealing that older brain and immune systems were linked to higher disease and death risks, while younger ones predicted longer life.
Patients with heart failure and atrial fibrillation (AF) at the time of mitral transcatheter edge-to-edge repair (M-TEER) for severe mitral regurgitation are more than twice as likely to die or be rehospitalized for heart failure, compared to patients without AF. These are the findings from a Mount Sinai Fuster Heart Hospital study that links the presence of AF at the time of the procedure to worse outcomes following the procedure.
A large imaging study found that even small increases in long-term exposure to fine particulate air pollution were linked to higher levels of myocardial fibrosis, a known marker of adverse heart remodeling, in both healthy individuals and patients with dilated cardiomyopathy.
A new ESC clinical statement finds that common vaccines, including those for influenza and COVID-19, may lower cardiovascular risks such as heart attack, stroke, and heart failure, particularly in high-risk patients.
New research shows body fat percentage predicts long-term mortality more accurately than BMI, suggesting a need to revise how body composition is measured in clinical care.
A morning BP rise of over 10 mmHg independently predicts left ventricular hypertrophy—accounting for 36.2% of LVMI variability, even after adjusting for age and BMI.